全文获取类型
收费全文 | 2595篇 |
免费 | 210篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 184篇 |
妇产科学 | 50篇 |
基础医学 | 323篇 |
口腔科学 | 114篇 |
临床医学 | 204篇 |
内科学 | 504篇 |
皮肤病学 | 59篇 |
神经病学 | 172篇 |
特种医学 | 234篇 |
外科学 | 421篇 |
综合类 | 44篇 |
预防医学 | 144篇 |
眼科学 | 63篇 |
药学 | 92篇 |
中国医学 | 2篇 |
肿瘤学 | 193篇 |
出版年
2023年 | 18篇 |
2022年 | 19篇 |
2021年 | 29篇 |
2020年 | 19篇 |
2019年 | 19篇 |
2018年 | 50篇 |
2017年 | 57篇 |
2016年 | 54篇 |
2015年 | 77篇 |
2014年 | 102篇 |
2013年 | 131篇 |
2012年 | 97篇 |
2011年 | 76篇 |
2010年 | 106篇 |
2009年 | 119篇 |
2008年 | 83篇 |
2007年 | 95篇 |
2006年 | 96篇 |
2005年 | 68篇 |
2004年 | 78篇 |
2003年 | 71篇 |
2002年 | 62篇 |
2001年 | 48篇 |
2000年 | 56篇 |
1999年 | 76篇 |
1998年 | 119篇 |
1997年 | 108篇 |
1996年 | 114篇 |
1995年 | 78篇 |
1994年 | 85篇 |
1993年 | 50篇 |
1992年 | 36篇 |
1991年 | 45篇 |
1990年 | 31篇 |
1989年 | 46篇 |
1988年 | 44篇 |
1987年 | 46篇 |
1986年 | 48篇 |
1985年 | 40篇 |
1984年 | 20篇 |
1983年 | 16篇 |
1982年 | 24篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1979年 | 11篇 |
1977年 | 13篇 |
1976年 | 17篇 |
1975年 | 16篇 |
1973年 | 9篇 |
1971年 | 10篇 |
排序方式: 共有2835条查询结果,搜索用时 15 毫秒
101.
102.
Falk Wehrhan Manuel Weber Christoph Baran Abbas Agaimy Maike Büttner-Herold Marco Kesting Jutta Ries 《Journal of cranio-maxillo-facial surgery》2021,49(2):118-125
ObjectivesThis study analyzed the expression of the PD1 receptor in tumor tissue and peripheral blood of oral squamous cell carcinoma (OSCC) patients, and correlated it with the PD1 ligands PD-L1 and PD-L2. The currently low response rates of checkpoint inhibitor treatment in OSCC could be increased by a better understanding of immune checkpoint biology. Despite evidence in the literature for upregulation of PD1 checkpoint ligands in OSCC tissue, there has been no correlation analysis of the PD1 receptor with its ligands in tissue specimens and peripheral blood of OSCC patients.Materials and methodsAn RT-qPCR analysis of PD1 mRNA expression was performed in oral cancer specimens, healthy mucosa, and corresponding blood samples. A cut-off point (COP) was determined and a chi-square (χ2) test was carried out. PD1 expression was correlated with previously reported PD-L1 and PD-L2 expression values using the Spearman test.ResultsTissue and blood specimens of 48 OSCC patients and 26 healthy individuals were analyzed. PD1 expression in OSCC specimens was significantly increased (p = 0.006) compared with healthy oral mucosa. PD1 overexpression in tissue samples showed a significant association with the presence of malignancy (p = 0.006). PD1 expression in tissue samples showed a significant positive correlation (p < 0.001) with the ligands PD-L1 and PD-L2. In contrast, there was no correlation between PD1 and its ligands in blood samples. However, there was a significant positive correlation (p < 0.001) between the ligands PD-L1 and PD-L2, both in tissue and blood samples.ConclusionsIncreased PD1 expression might be a manifestation of T-cell exhaustion in OSCC specimens, leading to immune tolerance. PD-L1/PD-L2-PD1 interaction may be a major mediator of local immunosuppression in OSCC, requiring advanced multimodal treatment protocols. 相似文献
103.
104.
105.
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen 总被引:1,自引:0,他引:1
We have studied the use of a new preparative regimen for the treatment of patients in remission of acute myeloid leukemia (AML) with autologous bone marrow transplantation. Chemotherapy consisted of busulfan 1 mg/kg every 6 hours for 4 days (total dose, 16 mg/kg) on days -7 through -4 followed by an intravenous infusion over 6 to 10 hours of etoposide 60 mg/kg on day -3. Autologous bone marrow, treated in vitro with 100 micrograms/mL of 4-hydroperoxycyclophosphamide, was infused on day 0. We have treated 58 patients up to the age of 60 years, 32 in first remission, 21 in second or third remission, and 5 with primary refractory AML unresponsive to high-dose Ara-C, but achieving remission with aggressive salvage regimens. Of the first remission patients, there has been 1 treatment related death and 5 relapses. With median follow-up of 22 months, the actuarial relapse rate is 22% +/- 9% and disease-free survival is 76% +/- 9% at 3 years. Patients with favorable French-American-British (FAB) subtypes (M3 or M4 EO) did especially well, with no relapses seen in 15 patients observed for a median of 30 months. Actuarial relapse rate at 3 years was 48% for first remission patients with less favorable FAB subtypes. Of patients in second or third remission, there were 5 treatment related deaths and 4 relapses. With median follow-up of 22 months, the actuarial relapse rate is 25% +/- 11% and disease-free survival is 56% +/- 11% at 3 years. Four of five primary refractory patients died during treatment and 1 remains in remission with short follow-up. These preliminary data are very encouraging and, if confirmed, support the use of autologous purged bone marrow transplantation using aggressive preparative regimens as one approach to improve the outcome of adults with AML. 相似文献
106.
Lineage-restricted regulation of the murine SCL/TAL-1 promoter 总被引:10,自引:2,他引:10
Bockamp EO; McLaughlin F; Murrell AM; Gottgens B; Robb L; Begley CG; Green AR 《Blood》1995,86(4):1502-1514
107.
Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice 总被引:15,自引:1,他引:15
The normal skin and other tissues of adult mast cell-deficient WBB6F1- W/Wv or WCB6F1-Sl/Sld mice contain less than 1.0% the number of mast cells present in the corresponding tissues of the congenic normal (+/+) mice. As a result, genetically mast cell-deficient WBB6F1-W/Wv or WCB6F1-Sl/Sld mice are widely used for studies of mast cell differentiation and function. We found that mast cells developed at sites of idiopathic chronic dermatitis in WBB6F1-W/Wv mice and that the number of mast cells present in the skin of WBB6F1-W/Wv mice was proportional to the severity of the dermatitis (in ear skin, there were 33 +/- 4 mast cells/mm2 of dermis at sites of severe dermatitis v 9 +/- 3 at sites of mild dermatitis, 0.8 +/- 0.3 in skin without dermatitis, and 100 +/- 7 in the normal skin of congenic WBB6F1-+/+ mice; in back skin, the corresponding values were 2.0 +/- 0.6, 1.1 +/- 0.9, 0.025 +/- 0.025, and 26.2 +/- 3.2). The development of mast cells was a local, not systemic, consequence of the dermatitis. Thus, WBB6F1-W/Wv mice with severe dermatitis lacked mast cells in skin not showing signs of dermatitis and also in the peritoneal cavity, stomach, cecum, and tongue. Idiopathic chronic dermatitis was not associated with the local development of mast cells in WCB6F1-Sl/Sld mice, a mutant whose mast cell deficiency is due to a mechanism distinct from that of WBB6F1-W/Wv mice. These findings may have implications for understanding the nature of the mast cell deficiency in WBB6F1-W/Wv and WCB6F1-Sl/Sld mice and for the use of these mutants to analyze mast cell differentiation and function. 相似文献
108.
109.
110.